I had posted last month about the Pegasystem pharmacovigilance solution.
Pega Systems the industry leader in Business Process Management (BPM) software solutions, released a Pharmacovigilance case processing software.
Pega has experience in clinical trial space, specifically in Clinical Trial Management. The solution is designed for rapid deployment to quickly leverage existing adverse event processing rules and requirements and can produce specialized documentation to help ensure compliance in a validated environment.
I have not come across any new updates after that. But apparently Accenture has acquired Knowledge Rules, Inc., a Philadelphia-based consulting company that focuses exclusively on implementing and integrating business solutions using Pegasystems’ Business Process Management (BPM) software.
Accenture has a very large Pharmacovigilance division serving several large pharmaceutical companies. It would not be very suprising if Accenture roles out the BPM software for their pharmacovigilance services.
I think that is a possibility because Accenture has announced plans to use the applications for all its Fortune 500 customers.
I would predict that United Health Group could be one of those customers as they are an existing customer of Pega.
Speaking of which Pega sounds like an attractive target Oracle can acquire